Rheumatology: Current Research
Open Access

The Role of B-cells in Rheumatic Fever-Related Autoimmune Responses

Shouyi Yong^{* *}Correspondence: Shouyi Yong, Department of Rheumatology and Immunology, Guangzhou University, Guangzhou, China, Email:

Author info »

About the Study

Rheumatic Fever (RF) is an autoimmune disease that arises as a complication of untreated or inadequately treated Group A Streptococcus (GAS) throat infection. It predominantly affects children and adolescents and can lead to serious sequelae, such as Rheumatic Heart Disease (RHD). The pathophysiology of RF involves an abnormal immune response, where the body’s immune system, specifically B-cells, plays a central role. Understanding the function and impact of B-cells in the development and progression of RF can provide insights into the disease’s mechanisms and potential therapeutic targets.

Immunological basis of rheumatic fever

RF is considered a classic example of molecular mimicry, wherein the immune system mounts an inflammatory response against self-antigens due to similarities between bacterial antigens and host tissues. GAS expresses surface proteins and Mproteins that resemble host cardiac and synovial tissue components, prompting cross-reactive immune responses. This can trigger an autoimmune reaction leading to tissue damage, including valvular heart disease and arthritis.

Role of B-cells in autoimmune responses

B-cells are a type of white blood cell that are important to adaptive immunity. Their primary function is the production of antibodies, which are key for neutralizing pathogens. In the context of autoimmune diseases such as RF, B-cells become hyperactive and produce antibodies that mistakenly target selfantigens.

Antibody production and autoantibody formation

In RF, B-cells are activated when they recognize GAS antigens. These activated B-cells differentiate into plasma cells and secrete antibodies. Some of these antibodies, however, cross-react with the host’s own tissues due to the molecular mimicry between bacterial M-proteins and cardiac myosin or collagen. This production of autoantibodies is a hallmark of autoimmune responses and contributes to tissue damage and inflammation seen in RF.

B-cells and their role beyond antibody production

While antibody production is the most well-known function of B-cells, they also play a role in antigen presentation and cytokine production. In RF, B-cells can present antigens to T-cells, leading to the activation of T-helper cells that promote inflammatory responses. Additionally, B-cells can secrete pro-inflammatory cytokines such as IL-6 and TNF-α, further amplifying the autoimmune reaction.

Genetic and environmental factors influencing Bcell activity

The hyperactivity of B-cells in RF is influenced by both genetic predispositions and environmental factors. Genetic studies have identified specific alleles, such as those related to the Human Leukocyte Antigen-DR isotype (HLA-DR) and Human Leukocyte Antigen DQ (HLA-DQ) regions that may increase susceptibility to autoimmune responses. These genetic factors can affect the expression of B-cell receptors and the affinity of antibodies for self-antigens. Environmental factors, such as repeated GAS throat infections, exacerbate these predispositions, leading to a higher incidence of RF.

Pathogenesis of cardiac involvement

The most severe consequence of RF is the development of RHD, which results from chronic inflammation and scarring of heart valves. B-cells contribute to this process by producing antibodies that can target cardiac proteins. The cross-reactive antibodies bind to the heart’s tissues, leading to complement activation and recruitment of immune cells that cause further tissue damage. This immune complex formation can create a cycle of ongoing inflammation and fibrosis, ultimately leading to valve deformity and stenosis.

B-cells in the development of valvular disease

B-cells are implicated not only in the acute phase of RF but also in the chronic progression to RHD. Over time, continuous antibody production and deposition of immune complexes in the heart valves can lead to chronic inflammation, fibrosis, and calcification. B-cell depletion studies in animal models have shown reduced severity of cardiac inflammation and valve damage, suggesting that targeting B-cell activity could be a viable therapeutic approach.

Therapeutic implications

Understanding the role of B-cells in RF has significant implications for treatment. Current approaches, such as antibiotics for GAS eradication and anti-inflammatory medications, address the initial triggers and inflammatory responses but do not specifically target B-cell activity. Therapies that inhibit B-cell activation or deplete B-cells, such as monoclonal antibodies (e.g., rituximab), may offer promise in preventing autoimmune responses and mitigating damage to the heart. Research into these targeted treatments is ongoing, and future studies may reveal more effective ways to manage RF and prevent RHD.

B-cells play a fundamental role in the autoimmune responses seen in rheumatic fever, from initiating antibody production against self-antigens to contributing to chronic inflammation and organ damage, especially in the heart. Understanding their function in RF pathogenesis provides an avenue for developing targeted therapeutic strategies.